DeLong Mark Jeffrey

Related Filers (1)

Other (5)

144
Monday, 2/12/2024
Filing for proposed sale of securities under Rule 144
144
Monday, 1/29/2024
Filing for proposed sale of securities under Rule 144
144
Monday, 1/22/2024
Filing for proposed sale of securities under Rule 144
144
Tuesday, 1/16/2024
Filing for proposed sale of securities under Rule 144
144
Monday, 10/23/2023
Filing for proposed sale of securities under Rule 144
Show More

Ownership (29)

4
Tuesday, 2/13/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/31/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/23/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/17/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/24/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/22/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/14/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/30/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/24/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/17/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 10/24/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/18/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/12/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/9/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/8/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/28/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/21/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/21/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/22/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/14/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4/A
Monday, 2/7/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/1/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/25/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/27/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/22/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/16/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/16/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/19/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 4/9/2021
Apellis Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
Show More